See also this year's filing and all EDGAR filings for this company.
PDF Report 0001178670_2011_Alnylam_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001178670, Alnylam Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 254,139,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 448,000 |
| 2 | PropertyPlantAndEquipmentNet | 18,289,000 |
| 3 | remainder_Assets | 120,389,000 |
| 4 | LiabilitiesCurrent | 102,046,000 |
| 5 | LiabilitiesNoncurrent | 143,000 |
| 6 | remainder_Liabilities | 132,843,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 37,727,000 |
| 9 | ResearchAndDevelopmentExpense | 106,384,000 |
| 10 | remainder_Expenses | 514,000 |
| 11 | remainder_Revenues | 100,041,000 |
| 12 | remainder_NetIncome | 1,069,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 393,265,000 |
| 1 | Liabilities | 235,032,000 |
| 2 | Expenses | 144,625,000 |
| 3 | Revenues | 100,041,000 |
| 4 | StockholdersEquity | 158,233,000 |
| 5 | NetIncome | -43,515,000 |
| 6 | ComprehensiveNetIncome | -43,516,000 |
| 7 | BaseVar | 437,017,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.960 |
| 9 | EconomicCapitalRatio | 2.27 |
Edgar->Model Mapping
Feature Distribution
